
DRMA vs JUNS
$DRMA vs $JUNS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DRMA vs JUNS: the quick read
- ·DRMA is the larger company by market cap ($7M vs $3M).
- ·JUNS has been more active on our scanner (105 vs 90 alerts in 30 days).
- ·JUNS has the smaller float (766K vs 4.1M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 105 and 90 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are pulling apart today: DRMA is outperforming the other by roughly 25.1 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DRMA and JUNS on TheDesperateTrader.
- Is DRMA or JUNS the better stock?
- "Better" depends on your goal, and these two are not alike. DRMA is the larger company by market cap ($7M vs $3M). JUNS has been more active on our scanner (105 vs 90 alerts in 30 days). JUNS has the smaller float (766K vs 4.1M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DRMA and JUNS?
- The differences that matter: they are similar in size ($7M vs $3M); they trade at very different share prices ($1.34 vs $3.13); DRMA sits at 7% of its 52-week range against 27% for JUNS; our scanner flagged DRMA 90 times in the last 30 days against 105 for JUNS. Everything above is measured from the latest completed session and SEC filings.
- Which of DRMA and JUNS is more active right now?
- Right now DRMA is at about 0.1x its normal volume and JUNS is at about 0.0x, so DRMA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DRMA or JUNS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DRMA and JUNS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.